National Cancer Institute; Amended Notice of Meeting
---
identifier: "/us/fr/2019-12070"
source: "fr"
legal_status: "authoritative_unofficial"
title: "National Cancer Institute; Amended Notice of Meeting"
title_number: 0
title_name: "Federal Register"
section_number: "2019-12070"
section_name: "National Cancer Institute; Amended Notice of Meeting"
positive_law: false
currency: "2019-06-10"
last_updated: "2019-06-10"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "2019-12070"
document_type: "notice"
publication_date: "2019-06-10"
agencies:
- "Health and Human Services Department"
- "National Institutes of Health"
fr_citation: "84 FR 26884"
fr_volume: 84
---
# National Cancer Institute; Amended Notice of Meeting
Notice is hereby given of a change in the meeting of the National Cancer Institute Clinical Trials and Translational Research Advisory Committee, Translational Research Strategy Subcommittee, June 19, 2019, 10 a.m. to 11 a.m. which was published in the *Federal Register* on May 24, 2019, 84 FR 24166.
This meeting notice is amended to change the meeting date and time of the Translational Research Strategy Subcommittee from June 19, 2019 from 10 a.m. to 11 a.m. to July 8, 2019 from 4 p.m. to 5 p.m. The meeting is open to the public.
Dated: June 4, 2019.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.